Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05587751 · ClinicalTrials.gov registry record · NA
Evaluation of Gender-Affirming Treatments on Pulmonary Function in Transgender and Gender Diverse Patients
A NA study of Hormonal Gender-Affirming Therapy, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- NA
- Development phase
- 44
- Enrollment target
- 1
- Study location
NCT05587751: Recruiting NA study of Hormonal Gender-Affirming Therapy, sponsored by Mayo Clinic.
NCT05587751 is a NA study of Hormonal Gender-Affirming Therapy that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 44 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05587751, a NA study of Hormonal Gender-Affirming Therapy, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- NA
- Development phase
- 44 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to evaluate whether undergoing gender affirming care will impact the way the lungs function.
Primary Outcome
The longitudinal changes in lung volumes after both masculinizing and feminizing hormone therapy in transgender and gender diverse (TGD) patients.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Spirometry
- DIAGNOSTIC_TEST Plethysmography
Study Locations (1)
Minnesota
- Mayo Clinic Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2023-02-01 |
| Est. Completion | 2027-07 |
| Phase | NA |
What NCT05587751 shows while recruiting
NCT05587751 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 44 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Hormonal Gender-Affirming Therapy appearing as the primary indexed condition, and to 2 interventions - of which Spirometry is the first listed.
NCT05587751 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT05587751 about?
NCT05587751 is a clinical study titled "Evaluation of Gender-Affirming Treatments on Pulmonary Function in Transgender and Gender Diverse Patients". The purpose of this research study is to evaluate whether undergoing gender affirming care will impact the way the lungs function.
What is the current status of trial NCT05587751?
This trial is currently recruiting. It is a NA study. The enrollment target is 44 participants. The study started on 2023-02-01. Estimated completion is 2027-07.
What conditions does trial NCT05587751 study?
This clinical trial studies the following conditions: Hormonal Gender-Affirming Therapy.
What interventions are being tested in trial NCT05587751?
The interventions under investigation include: Spirometry (DIAGNOSTIC_TEST), Plethysmography (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05587751?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05587751 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05587751's enrollment target sits among peer trials
44 1423rd of 2000 higher than 566 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02323945 · 44 participants · NA
Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury
- NCT03093909 · 44 participants · Phase 1
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
- NCT03104491 · 44 participants · Phase 1
Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia
- NCT03781765 · 44 participants · Phase 4
Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI